SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-22-003202
Filing Date
2022-08-22
Accepted
2022-08-22 15:08:40
Documents
42
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk2228367.htm   iXBRL 10-Q 904192
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 8385
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 8343
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4791
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 4769
  Complete submission text file 0001178913-22-003202.txt   3110998

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atms-20220630.xsd EX-101.SCH 31140
7 XBRL CALCULATION FILE atms-20220630_cal.xml EX-101.CAL 28310
8 XBRL DEFINITION FILE atms-20220630_def.xml EX-101.DEF 63600
9 XBRL LABEL FILE atms-20220630_lab.xml EX-101.LAB 387827
10 XBRL PRESENTATION FILE atms-20220630_pre.xml EX-101.PRE 131692
36 EXTRACTED XBRL INSTANCE DOCUMENT zk2228367_htm.xml XML 326034
Mailing Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507
Business Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 221183561
SIC: 2890 Miscellaneous Chemical Products